Dear Readers,
I have highlighted a variety of opportunities if you have a couple of languages, but as it happens, there are also a lot of opportunities in the pharmaceutical or medical device industry.
I was reading in the Sunday Times about an upskilling course to obtain skills to enter this area of employment.
Do you have a background in Manufacturing, Construction, Engineering or Science Industries?
Are you currently unemployed? Would you like to Convert your Expertise to the Pharmaceutical
Successful candidates will complete a selection of the following modules:
Manufacturing and Process Technology
cGMP (Current Good Manufacturing Practice)
Quality Assurance
Introduction to Pharmaceutical Science
Systems Validation
Bioprocess Technology
Pharmaceutical Biotechnology
Formulations Studies and Packaging
Process Analytical Technology
Chemical Engineering
Control Engineering
Materials Properties and Processing
Quality Risk Management
Lean Sigma
Creative Problem Solving & Root Cause Analysis
Technical Report Writing & Project Management
Team Participation Skills
Academic modules will be accredited through single subject certification and can be used towards
existing HETEC Diploma and Degree programmes. Further certification will be given for industry
recognised accreditation.
Ideally applicants will:
a) have a qualification in Engineering or Science to Bachelor degree level, or higher, or in excess
of 5 years experience in a manufacturing environment and relevant qualifications.
b) be currently unemployed.
(Note: Successful candidates may be entitled to retain Social Welfare payments for so long as they are entitled to receive such payments under D/SFA eligibility rules.
Application Forms and further details are available by e-mailing
callano@innopharmalabs.com. Closing date for applications is January 21st.
This is just some background information on Ireland’s pharmaceutical industry, taken from the http://www.innopharmalabs.com/ website :
As we speak there are nine major ongoing capital investments, totalling over €1.5 billion ‐ at Centocor,
Eli‐Lilly, Glaxo‐SmithKline, Gilead and Pfizer in Cork, at Genzyme and Servier in Waterford and at Merck Sharp and Dohme in Clonmel and Carlow. More significant is the fact that most of these investments are in Biotech or R&D ‐ the cutting edge of the sector. This bodes very well for the long‐term future of the industry in this country.’
Ian Jones, CEO Innopharma Labs emphasizes ‘The pharmaceutical sector is still critical to our economy. We rely on it for over 50% of our exported goods. We can’t forget this. We need to support it maximally. We need to be lean in how we manufacture pharmaceutical products. This needs to be reflected in the people and the technologies introduced to the industry. Innopharma Labs aims to do this with our research and education partners. We love what we do and believe it benefits the Irish pharmaceutical sector’
Hope this will come in handy for someone out there.
Regards,
Katleen
